Positron Emission Tomography with 18F Fluorodeoxyglucose for Primary Lymphoma of Bone / 대한핵의학회잡지
Korean Journal of Nuclear Medicine
;
: 331-335, 2003.
Artigo
em Coreano
| WPRIM
| ID: wpr-46052
ABSTRACT
PURPOSE:
Accurate assessment of the lesion after treatment of patients with bone lymphoma is difficult. In this patient who demonstrated complete remission after chemotherapy, the regions of fluorine-18 fluorodeoxyglucose ( (18) FFDG) PET uptake diminished more rapidly following therapy, indicating a complete response at much earlier stage than did Magnetic Resonance Imaging (MRI) or CT based findings. With the conventional methods, such as MRI and CT, it was difficult to assess whether the residual tumor tissue was viable or not. Decision to complete response is very important in patients with lymphoma to plan the further treatment. We experienced a patient with primary lymphoma of bone who revealed complete response to chemotherapy on (18) FFDGPET while CT showed persistent destructive bone lesion. Thus, (18) FFDGPET study after therapy may be superior to CT in the evaluation of response to treatment in primary lymphoma of bone.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Imageamento por Ressonância Magnética
/
Neoplasia Residual
/
Fluordesoxiglucose F18
/
Tomografia por Emissão de Pósitrons
/
Tratamento Farmacológico
/
Elétrons
/
Linfoma
Limite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Nuclear Medicine
Ano de publicação:
2003
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS